Telemus Capital, LLC Bristol Myers Squibb CO Transaction History

Telemus Capital, LLC

$1.2 Billion
Q4 2023

A detailed history of Telemus Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Telemus Capital, LLC holds 25,110 shares of BMY stock, worth $1.34 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

25,110

Previous 25,657 2.13%

Holding current value

$1.34 Million

Previous $1.49 Million 13.5%

% of portfolio

0.11%

Previous 0.14%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$48.48 - $57.85 $26,518 - $31,643	-547 Reduced 2.13%	25,110 $1.29 Million
Q3 2023 Oct 25, 2023	SELL	$57.89 - $64.73 $83,824 - $93,729	-1,448 Reduced 5.34%	25,657 $1.49 Million
Q2 2023 Jul 10, 2023	BUY	$63.71 - $70.74 $57,912 - $64,302	909 Added 3.47%	27,105 $1.73 Million
Q1 2023 Apr 11, 2023	BUY	$65.71 - $74.53 $54,539 - $61,859	830 Added 3.27%	26,196 $1.82 Million
Q4 2022 Jan 11, 2023	SELL	$68.48 - $81.09 $32,801 - $38,842	-479 Reduced 1.85%	25,366 $0
Q3 2022 Oct 11, 2022	BUY	$0.13 - $76.84 $44 - $26,279	342 Added 1.34%	25,845 $1.84 Million
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $170,439 - $187,713	-2,347 Reduced 8.43%	25,503 $1.96 Million
Q1 2022 Apr 06, 2022	BUY	$61.48 - $73.72 $7,377 - $8,846	120 Added 0.43%	27,850 $2.03 Million
Q4 2021 Feb 01, 2022	SELL	$53.63 - $62.52 $29,979 - $34,948	-559 Reduced 1.98%	27,730 $1.73 Million
Q3 2021 Oct 27, 2021	SELL	$59.17 - $69.31 $448,863 - $525,785	-7,586 Reduced 21.15%	28,289 $1.67 Million
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $114,285 - $124,457	-1,846 Reduced 4.89%	35,875 $2.4 Million
Q1 2021 Apr 20, 2021	BUY	$59.34 - $66.74 $458,223 - $515,366	7,722 Added 25.74%	37,721 $2.38 Million
Q4 2020 Jan 28, 2021	BUY	$57.74 - $65.43 $111,957 - $126,868	1,939 Added 6.91%	29,999 $1.86 Million
Q3 2020 Nov 02, 2020	BUY	$57.43 - $63.64 $366,862 - $406,532	6,388 Added 29.48%	28,060 $1.72 Million
Q2 2020 Jul 17, 2020	SELL	$54.82 - $64.09 $4,111 - $4,806	-75 Reduced 0.34%	21,672 $1.25 Million
Q1 2020 Jun 05, 2020	SELL	$46.4 - $67.43 $346,700 - $503,836	-7,472 Reduced 25.57%	21,747 $1.3 Million
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $417,497 - $544,587	8,484 Added 40.92%	29,219 $1.88 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $12,831 - $15,213	300 Added 1.47%	20,735 $1.05 Million
Q2 2019 Aug 09, 2019	SELL	$44.62 - $49.34 $47,564 - $52,596	-1,066 Reduced 4.96%	20,435 $927,000
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $22,875 - $27,276	-507 Reduced 2.3%	21,501 $1.03 Million
Q4 2018 Feb 06, 2019	SELL	$48.76 - $63.23 $80,454 - $104,329	-1,650 Reduced 6.97%	22,008 $1.14 Million
Q3 2018 Oct 23, 2018	SELL	$55.19 - $62.25 $21,855 - $24,651	-396 Reduced 1.65%	23,658 $1.47 Million
Q2 2018 Jul 31, 2018	BUY	$50.53 - $62.98 $7,023 - $8,754	139 Added 0.58%	24,054 $1.33 Million
Q1 2018 Apr 27, 2018	SELL	$59.92 - $68.98 $15,279 - $17,589	-255 Reduced 1.06%	23,915 $1.51 Million
Q4 2017 Feb 02, 2018	BUY	$59.94 - $65.35 $1.15 Million - $1.25 Million	19,129 Added 379.47%	24,170 $1.48 Million
Q3 2017 Nov 03, 2017	SELL	$55.23 - $63.74 $413,617 - $477,348	-7,489 Reduced 59.77%	5,041 $321,000
Q2 2017 Apr 03, 2018	BUY	N/A	1,155 Added 10.15%	12,530 $698,000
Q1 2017 Apr 03, 2018	BUY	N/A	11,375	11,375 $619,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemus Capital, LLC with notifications on news.

Account

Telemus Capital, LLC Bristol Myers Squibb CO Transaction History